首页> 外国专利> USE OF N-6 OR N-3 SERIES ESSENTIAL FATTY ACID (EFA), AND OPTIONALLY AN OESTROGEN, TO MAKE A MEDICAMENT TO TREAT OR PREVENT HORMONE REPLACEMENT THERAPY (HRT) ASSOCIATED BREAST PAIN IN PERI- OR POSTMENOPAUSAL WOMEN; MEDICAMENTS CONTAINING THE EFA AND ESTROGEN.

USE OF N-6 OR N-3 SERIES ESSENTIAL FATTY ACID (EFA), AND OPTIONALLY AN OESTROGEN, TO MAKE A MEDICAMENT TO TREAT OR PREVENT HORMONE REPLACEMENT THERAPY (HRT) ASSOCIATED BREAST PAIN IN PERI- OR POSTMENOPAUSAL WOMEN; MEDICAMENTS CONTAINING THE EFA AND ESTROGEN.

机译:使用N-6或N-3系列必需脂肪酸(EFA)和可选的雌激素来治疗或预防围绝经期或绝经后妇女的激素替代治疗(HRT)的乳房疼痛;含有EFA和雌激素的药物。

摘要

A method of treatment or prevention of, or a method of making a medicament for the treatment or prevention of, hormone replacement therapy-associated breast pain in peri- or post-menopausal women, wherein an n-6 or n-3 series essential fatty acid is used as an active of said medicament or in said therapy, optionally with a natural or synthetic replacement therapy oestrogen.
机译:在围绝经期或绝经后妇女中,与激素替代疗法相关的乳房疼痛的治疗或预防方法,或制备用于治疗或预防的药物的方法,其中n-6或n-3系列必需脂肪酸用作所述药物的活性物质或在所述疗法中,任选地与天然或合成替代疗法雌激素一起使用。

著录项

  • 公开/公告号NZ280017A

    专利类型

  • 公开/公告日1997-06-24

    原文格式PDF

  • 申请/专利权人 SCOTIA HOLDINGS PLC;

    申请/专利号NZ19950280017

  • 发明设计人 HORROBIN DAVID FREDERICK;

    申请日1995-09-14

  • 分类号A61K31/20;A61K31/565;

  • 国家 NZ

  • 入库时间 2022-08-22 03:25:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号